Article Correctness Is Author's Responsibility: Closing of Second Antibiotic Company Highlights Urgent Need for Investment in Infection Fighting Drugs

Earlier today, a release was issued stating that antibiotic maker Melinta is closing. This information was incorrect. Melinta has filed for Chapter 11 bankruptcy but intends to remain open and is in the process of restructuring. The bankruptcy filing announced today by antibiotic maker Melinta once again highlights the daunting challenges facing research and development of new infection-fighting drugs.